|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0419 | ED148506 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 7 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0881 | ED148042 | General Research Use | No | Male | White | 82 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1379 | ED149312 | General Research Use | No | Male | White | 63 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1678 | ED148133 | General Research Use | No | Male | White | 83 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2562 | ED148827 | General Research Use | No | Female | White | 56 | 8 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2757 | ED148757 | General Research Use | No | Male | White | 75 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3449 | ED148491 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0004 | ED149536 | General Research Use | No | Female | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_1103 | ED149782 | General Research Use | No | Female | White | 76 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1259 | ED148786 | General Research Use | No | Female | White | 64 | 8 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2138 | ED149997 | General Research Use | No | Female | White | 75 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_2685 | ED148669 | General Research Use | No | Male | White | 84 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_3070 | ED149717 | General Research Use | No | Female | White | 60 | 8 - AREDS AMD Severity Scale Step 8 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3204 | ED149269 | General Research Use | No | Female | White | 81 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_4162 | ED149758 | General Research Use | No | Male | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0452 | ED149352 | General Research Use | No | Female | White | 62 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |
| AR2_0543 | ED148544 | General Research Use | No | Female | White | 72 | 8 - AREDS AMD Severity Scale Step 8 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0651 | ED150026 | General Research Use | No | Female | White | 77 | 8 - AREDS AMD Severity Scale Step 8 | 10 - Central GA |
| AR2_0663 | ED148564 | General Research Use | No | Female | White | 84 | 8 - AREDS AMD Severity Scale Step 7 | 10 - Central GA |
| AR2_1576 | ED149621 | Eye Disease Only | No | Female | White | 78 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |